Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Accenture
Baxter
McKinsey
AstraZeneca
Colorcon
Chubb
UBS
US Army
Chinese Patent Office

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020805

« Back to Dashboard

NDA 020805 describes CIPRO HC, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. Additional details are available on the CIPRO HC profile page.

The generic ingredient in CIPRO HC is ciprofloxacin hydrochloride; hydrocortisone. There are thirty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride; hydrocortisone profile page.
Summary for 020805
Tradename:CIPRO HC
Applicant:Novartis Pharms Corp
Ingredient:ciprofloxacin hydrochloride; hydrocortisone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020805
Ingredient-typeQuinolones
Mechanism of ActionCorticosteroid Hormone Receptor Agonists
Suppliers and Packaging for NDA: 020805
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805 NDA Alcon Laboratories, Inc. 0065-8531 N 0065-8531-10
CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805 NDA Physicians Total Care, Inc. 54868-4365 E 54868-4365-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OTICStrengthEQ 0.2% BASE;1%
Approval Date:Feb 10, 1998TE:RLD:Yes

Expired US Patents for NDA 020805

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Farmers Insurance
Queensland Health
Cantor Fitzgerald
Accenture
Moodys
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot